146 related articles for article (PubMed ID: 3718408)
21. [Antithrombin III in hip surgery].
Weber U; Schöndorf TH; Rettig H
Z Orthop Ihre Grenzgeb; 1984; 122(1):16-9. PubMed ID: 6702257
[TBL] [Abstract][Full Text] [Related]
22. Benefit/risk profile of high-dose antithrombin in patients with severe sepsis treated with and without concomitant heparin.
Hoffmann JN; Wiedermann CJ; Juers M; Ostermann H; Kienast J; Briegel J; Strauss R; Warren BL; Opal SM;
Thromb Haemost; 2006 May; 95(5):850-6. PubMed ID: 16676077
[TBL] [Abstract][Full Text] [Related]
23. Reduced alpha-2-antiplasmin levels in the nephrotic syndrome.
Francis RB; Sandler RM; Levitan D; Feinstein EI; Massry SG; Feinstein DI
Nephron; 1985; 39(4):325-9. PubMed ID: 3157072
[TBL] [Abstract][Full Text] [Related]
24. [Thrombo-embolic disease as a complication of nephrotic syndrome in children].
Jarmoliński T; Zachwieja J; Bortkiewicz E; Stachowski J; Maciejewski J
Pediatr Pol; 1996 May; 71(5):437-41. PubMed ID: 8710427
[TBL] [Abstract][Full Text] [Related]
25. [Pathogenetic mechanism and clinical relevance of acquired anti-thrombin III deficiency in internal medicine (author's transl)].
Thaler E
Wien Klin Wochenschr; 1981 Oct; 93(18):563-72. PubMed ID: 7029926
[TBL] [Abstract][Full Text] [Related]
26. Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in nephrotic syndrome.
Boneu B; Bouissou F; Abbal M; Sie P; Caranobe C; Barthe P
Thromb Haemost; 1981 Oct; 46(3):623-5. PubMed ID: 6171906
[TBL] [Abstract][Full Text] [Related]
27. [Etiology, clinical significance and therapy of antithrombin III deficiencies].
Lechner K; Thaler E; Niessner H
Acta Med Austriaca; 1983; 10(5):129-35. PubMed ID: 6666509
[No Abstract] [Full Text] [Related]
28. Outcome after kidney transplantation in children with thrombotic risk factors.
Kranz B; Vester U; Nadalin S; Paul A; Broelsch CE; Hoyer PF
Pediatr Transplant; 2006 Nov; 10(7):788-93. PubMed ID: 17032424
[TBL] [Abstract][Full Text] [Related]
29. [Antithrombin III deficiency as a risk factor in postoperative thrombosis].
Van Betsbrugge M
Acta Chir Belg; 1985; 85(5):299-302. PubMed ID: 4082851
[TBL] [Abstract][Full Text] [Related]
30. High plasma levels of protein C activity and antigen in the nephrotic syndrome.
Mannucci PM; Valsecchi C; Bottasso B; D'Angelo A; Casati S; Ponticelli C
Thromb Haemost; 1986 Feb; 55(1):31-3. PubMed ID: 3754658
[TBL] [Abstract][Full Text] [Related]
31. [Significance of disordered antithrombin III function in disseminated intravascular coagulation and deep venous thrombosis for anticoagulant therapy].
von Blohn G; Reiter B; Hellstern P; Wenzel E; Köhler M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):426-38. PubMed ID: 6083907
[TBL] [Abstract][Full Text] [Related]
32. Antithrombin III deficiency, deep venous thrombosis, and oral contraceptive use.
Werner MJ
J Adolesc Health; 1995 Sep; 17(3):189-92. PubMed ID: 8519788
[TBL] [Abstract][Full Text] [Related]
33. [Role of antithrombin III determination in various pregnancy and puerperal complications].
Makatsariia AD; Nesterova SG
Akush Ginekol (Mosk); 1982 May; (5):27-9. PubMed ID: 7102979
[No Abstract] [Full Text] [Related]
34. Coagulation and renal diseases.
Kanfer A
Proc Eur Dial Transplant Assoc; 1983; 19():703-13. PubMed ID: 6348762
[No Abstract] [Full Text] [Related]
35. [Antithrombin III in infantile nephrotic syndrome].
Lorusso L; Miniello VL; Francioso G; Aceto G; DiBitonto G; Penza R
Boll Soc Ital Biol Sper; 1982 Sep; 58(17):1093. PubMed ID: 7138678
[TBL] [Abstract][Full Text] [Related]
36. [Acquired and congenital antithrombin III deficiency. Discussion of a clinical case].
De Blasio F; De Filippis R; Bucci N; Formato A; Pezza A
Arch Monaldi Mal Torace; 1987; 42(2):205-13. PubMed ID: 3333220
[No Abstract] [Full Text] [Related]
37. Cerebral venous thrombosis in nephrotic syndrome.
Akatsu H; Vaysburd M; Fervenza F; Peterson J; Jacobs M
Clin Nephrol; 1997 Nov; 48(5):317-20. PubMed ID: 9403217
[TBL] [Abstract][Full Text] [Related]
38. [Antithrombin III deficiency in the nephrotic syndrome. Threatened thrombosis treated with fresh plasma].
Frifelt JJ; Jørgensen KA; Rosleff F
Ugeskr Laeger; 1984 Jul; 146(28):2092-3. PubMed ID: 6515799
[No Abstract] [Full Text] [Related]
39. Antithrombin substitution therapy.
Schinzel H; Weilemann LS
Blood Coagul Fibrinolysis; 1998 Nov; 9 Suppl 3():S17-21; discussion S21-2. PubMed ID: 10102495
[TBL] [Abstract][Full Text] [Related]
40. Antithrombin III concentrates--are they clinically useful?
Lechner K; Kyrle PA
Thromb Haemost; 1995 Mar; 73(3):340-8. PubMed ID: 7667814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
